You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MAPK

Showing 1 - 25 of 415
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors With MAPK Pathway Mutations Trial in Nedlands (D3S-002)

Not yet recruiting
  • Advanced Solid Tumors With MAPK Pathway Mutations
  • Nedlands, Western Australia, Australia
    D3 Bio Investigative Site
May 24, 2023

Rosacea, Erythematotelangiectatic Trial in Albany (Trametinib)

Recruiting
  • Rosacea, Erythematotelangiectatic
  • Albany, New York
    Samuel S. Stratton VA Medical Center
Nov 9, 2022

Gliomas Trial in Houston (Ulixertinib)

Not yet recruiting
  • Gliomas
  • Houston, Texas
    M D Anderson Cancer Center
Apr 12, 2023

Influenza, Human Trial in Leiden (POLB 001, Placebo)

Completed
  • Influenza, Human
  • POLB 001
  • Placebo
  • Leiden, Netherlands
    Centre for Human Drug Research
Mar 13, 2023

Advanced Solid Tumors Harboring MAPK Pathway Alterations Trial in Shandong (QLH11906)

Recruiting
  • Advanced Solid Tumors Harboring MAPK Pathway Alterations
  • Shandong, China
    Shandong Cancer Hospital
Aug 3, 2022

Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

Recruiting
  • Solid Tumor
  • +3 more
  • Denver, Colorado
  • +2 more
Dec 19, 2022

Advanced Cancer, Metastatic Cancer, Solid Tumor Trial in United States (JZP815)

Recruiting
  • Advanced Cancer
  • +2 more
  • Denver, Colorado
  • +4 more
Jan 10, 2023

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Metastatic Thyroid Cancer Trial in Essen (Trametinib 2 MG [Mekinist], Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2)

Recruiting
  • Metastatic Thyroid Cancer
  • Trametinib 2 MG [Mekinist]
  • Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2) [Tafinlar]
  • Essen, Northrhine-Westphalia, Germany
    Manuel M. Weber
May 17, 2022

Gastrointestinal Tumors Trial in Salt Lake City (Ulixertinib, Hydroxychloroquine)

Recruiting
  • Gastrointestinal Neoplasms
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Mar 1, 2022

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

Active, not recruiting
  • Low-grade Glioma
  • +2 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 25, 2022

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Acute Myeloid Leukemia Trial in United States (ERAS-007, ERAS-601, Gilteritinib)

Withdrawn
  • Acute Myeloid Leukemia
  • San Francisco, California
  • +3 more
Jun 13, 2022

Tumor, Solid, Gastrointestinal Cancer Trial in San Francisco, Ann Arbor (Ulixertinib, Hydroxychloroquine)

Recruiting
  • Tumor, Solid
  • Gastrointestinal Cancer
  • Tucson, Arizona
  • +7 more
Jan 13, 2023

NSCLC, KRAS Mutation-Related Tumors Trial in Philadelphia (Binimetinib Pill, Hydroxychloroquine Pill)

Recruiting
  • Non-Small Cell Lung Cancer
  • KRAS Mutation-Related Tumors
  • Binimetinib Pill
  • Hydroxychloroquine Pill
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 30, 2022

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

RAS Mutation, Neurofibromatosis 1, Noonan Syndrome Trial in Cincinnati

Recruiting
  • RAS Mutation
  • +13 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Feb 24, 2022

    Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

    Recruiting
    • Thyroid Cancer
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 19, 2023

    Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

    Recruiting
    • Melanoma
    • Solid Tumor
    • Los Angeles, California
    • +13 more
    Jul 27, 2022

    Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer Trial in United States (Mirdametinib, Fulvestrant)

    Recruiting
    • Breast Cancer
    • +6 more
    • Middletown, New Jersey
    • +3 more
    Dec 28, 2021

    Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +108 more
    Oct 19, 2022

    Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

    Not yet recruiting
    • Recurrent Biliary Tract Carcinoma
    • +13 more
    • (no location specified)
    Nov 8, 2022

    Resistance-associated Mutations in Metastatic Lung Cancer

    Recruiting
    • Lung Cancer
    • Liquid biopsy
    • Monza, MB, Italy
      Fondazione IRCCS San Gerardo dei Tintori
    Oct 10, 2023